PCRX

Pacira Pharmaceuticals, Inc. News Headlines

$96.25
*  
1.37
1.44%
Get PCRX Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading PCRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pacira: Should You Buy The Dip?
11/6/2014 10:16:00 AM - Seeking Alpha


Pacira Down on Wider than Expected Q3 Loss, Sales Miss - Analyst Blog
10/31/2014 12:00:00 PM - Zacks.com


Pacira Pharmaceuticals Q3 14 Earnings Conference Call At 9:00 AM ET
10/30/2014 8:01:00 AM - RTT News


Astellas Files for Amendment of Isavuconazole Study Protocol - Analyst Blog
10/17/2014 4:15:00 PM - Zacks.com


Pacira Pharmaceuticals, Inc. (PCRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
10/17/2014 7:00:00 AM - Zacks.com


Pacira Pharmaceuticals (PCRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
10/16/2014 7:45:00 AM - Zacks.com


Sucampo/Takeda Amend Collaboration Agreement for Amitiza - Analyst Blog
10/15/2014 5:07:00 PM - Zacks.com


Pacira (PCRX) Reveals Additional Safety Data on Exparel - Analyst Blog
10/14/2014 4:45:00 PM - Zacks.com


Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog
10/14/2014 4:30:00 PM - Zacks.com


Pacira Says Data Shows Safety Of EXPAREL Similar To Placebo And Bupivacaine HCl
10/13/2014 4:10:00 PM - RTT News


Astellas' New Data on Cresemba for Invasive Mucormycosis - Analyst Blog
10/9/2014 4:30:00 PM - Zacks.com


Heat Biologics Completes Dosing for Vesigenurtacel-L Trial - Analyst Blog
10/9/2014 2:54:00 PM - Zacks.com


Alcobra Reveals ADHD Top-line Phase III Data, Shares Down - Analyst Blog
10/8/2014 1:28:00 PM - Zacks.com


Pacira Down on Receipt of FDA Warning Letter for Exparel - Analyst Blog
9/29/2014 1:38:00 PM - Zacks.com


Shire Resolves Litigation Related to Vyvanse, Adderall XR - Analyst Blog
9/25/2014 4:20:00 PM - Zacks.com


Pacira Pharma Receives FDA Warning Letter Regarding Exparel
9/25/2014 11:25:00 AM - RTT News


FDA Issues Warning Letter To Pacira Pharma Regarding EXPAREL
9/25/2014 6:40:00 AM - RTT News


OPKO Health (OPK) Reports Positive Data on Rayaldee Trial - Analyst Blog
9/24/2014 3:36:00 PM - Zacks.com


Alcobra Finishes Follow-up Visits on Phase III Trial on MDX - Analyst Blog
9/23/2014 4:35:00 PM - Zacks.com


Dynavax (DVAX) Completes Enrolment for Study on Heplisav - Analyst Blog
9/23/2014 4:00:00 PM - Zacks.com


InsiderInsights.com Daily Round Up 9/2/14: Republic Services, Southern Copper, TJX And Regis
9/3/2014 11:53:00 AM - Seeking Alpha


Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside
8/22/2014 12:01:00 PM - Seeking Alpha


InsiderInsights.com Daily Round Up: 8/12/14
8/13/2014 12:40:00 AM - Seeking Alpha


Pacira Up on Narrower-than-Expected Loss, Revenue Beat in Q2 - Analyst Blog
8/4/2014 11:10:00 AM - Zacks.com


Update: Pacira Delivers Q2 Earnings Above Expectations
7/31/2014 1:38:00 PM - Seeking Alpha